Wohua pharmaceutical products cover more than ten kinds of dosage forms, such as tablets, capsules, oral liquids, pills, powders, ointments, mixtures, biological diagnostic reagents, etc. 100 varieties. The main products are Youxikeshu Tablets, Amber Xiaoshi Granules, Du Yuan Hanbi Liquid, Orange Pear Paste, Du Yuan Ganmao Granules, Baobaole Granules and Antiviral Oral Liquid. There are 8 national protected varieties of traditional Chinese medicine, 3 of which are exclusive protected varieties, and 43 varieties such as Xinkeshu tablets are listed in the national basic medical insurance catalogue. Its three varieties, such as Central Keshu Tablet, are exclusively protected by the state, and the leading product, Xinkeshu Tablet, was listed in the Catalogue of Products with High Quality and Good Price by the National Development and Reform Commission in 2007, and obtained the national patent.
As a major manufacturer of pure natural plant-based Chinese patent medicines for cardiovascular and cerebrovascular diseases in China, Wohua Medicine takes the field of cardiovascular and cerebrovascular drugs as the long-term development direction, focusing on the market segment of pure natural plant-based Chinese patent medicines for cardiovascular and cerebrovascular diseases, and is committed to developing the company into one of the largest manufacturers of pure natural plant-based Chinese patent medicines for cardiovascular and cerebrovascular diseases in China. The development strategy has been formulated, that is, to focus on the field of cardiovascular and cerebrovascular Chinese patent medicines for a long time, continuously develop products related to prevention, treatment and rehabilitation, build a first-class service platform, focus on product management, supplemented by capital operation, persist in being practical, specialized, stronger and bigger, enhance core competitiveness, meet the diverse needs of cardiovascular and cerebrovascular doctors and patients, establish a profitable and sustainable operation mode, and build itself into the most respected by experts, doctors and patients in the field of cardiovascular and cerebrovascular Chinese patent medicines in China.
Focusing on the development strategy of the company, the company insists on the combination of independent research and development and joint research and development, focusing the main direction of research and development on pure natural plant cardiovascular and cerebrovascular drugs. With its unique R&D advantages, it has formed a product and technology development model of "screening generation, demonstration generation, project generation, research generation, listing generation and reserve generation". The company is recognized as a national high-tech enterprise with its strong scientific research strength and continuous innovation ability.
The exclusive traditional Chinese medicine protection variety "Xinkeshu Tablet" developed by Wohua Medicine has scientific formula, exact and unique curative effect, no toxic and side effects and the best cost performance. It has been put into clinical practice for more than 20 years, becoming the first choice drug for patients with cardiovascular and cerebrovascular diseases, and is favored by doctors and patients. It was rated as a famous brand product of traditional Chinese medicine in China. The "Xinkeshu Dripping Pill" project under development is listed as "National 863 Key Science and Technology Project", "National Small and Medium-sized Enterprise Science and Technology Innovation Project" and "Shandong High-tech Key Project" respectively. Other series of drugs around cardiovascular and cerebrovascular pure natural plants have obtained production numbers, and some of them are under planned research and development.
Wohua Pharmaceutical has always followed the business philosophy of "people are good at medicine and medicine is good for people", and it has become the essence and tradition of Wohua Pharmaceutical to be good at medicine first. Quality has always been regarded as the cornerstone of enterprise survival, and efforts have been made to build a modern Chinese medicine industry chain that meets industry standards. We have invested huge sums of money to purchase domestic first-class advanced equipment and completely transformed the production workshop. By the end of 2003, all dosage forms of the company had passed GMP certification. The planting base of Chinese herbal medicine in line with GAP is under construction. A powerful quality assurance system has been established from the selection of medicinal materials to the whole production process and after-sales service. In recent years, all raw materials and finished products have passed the quality sampling inspection conducted by national, provincial and municipal drug inspection departments, and have been awarded the honorary titles of "quality star enterprise" and "assured pharmaceutical factory" by provincial and municipal food and drug administration for many times.
Wohua Medicine insists on marketing as the leading factor. After more than 20 years' efforts, according to the characteristics of cardiovascular and cerebrovascular prescription drugs, a stable marketing network and professional sales team have been established by adopting the model of professional clinical promotion as the mainstay and OTC as the supplement. At present, 22 offices have been set up in China, and business relations have been established with more than 300 commercial companies, more than 2,200 hospitals, nearly 10000 outpatient clinics and large pharmacies. Products cover more than 90 cities in 29 provinces and cities across the country. Through the implementation of academic, service and cultural marketing, while reforming the standardized marketing system, the market resources are in the hands of the company, and the budget input-output assessment is carried out, which basically puts an end to the waste and ineffective investment of marketing expenses. In recent years, under the premise of controlling the sales expense rate budget, the sales revenue has increased substantially.
Wohua Medicine always adheres to the people-oriented concept, insists on having both ability and political integrity, puts morality first, emphasizes ability and performance, appoints people on merit, respects the openness of knowledge and talents, and has an enlightened concept of selecting and employing people, paying special attention to the cultivation and development of existing personnel. At the same time, open the door, attract elites from all walks of life to join us, strive to build a learning and complementary team, and establish an effective incentive mechanism, which has laid a solid human resource foundation for the company's sustainable development.
Wohua Medicine constantly pursues and promotes the standardization and optimization of management. According to the modern enterprise system and the requirements of listed companies, the corporate governance structure has been improved, a unique flat organizational structure has been set up, and a complete set of perfect, practical, strict and scientific institutional systems have been formed. The management measures such as deepening and refining performance appraisal, comprehensively strengthening budget management, bidding price comparison, reducing costs and increasing efficiency have not only embodied the people-oriented management characteristics, but also realized refined management and stepped into modernization.
In order to ensure the implementation of the development strategy, Wohua Medicine attaches great importance to and emphasizes the improvement of execution, and puts forward the "six most" execution behavior orientation and requirements in the management team, namely: the most passionate struggle, the most direct communication, the most rapid action, the closest team, the most in-depth visit and the most full responsibility. Regular assessment, rewards and punishments linked to promote the coordination and efficiency of management.
Wohuaren will always keep in mind and undertake the core mission of "creating outstanding value for human health", inherit and carry forward the core values of "customer first, serving others, being honest and innovative", and pursue corporate vision who is good at medicine, medicine and people.